22/01/2026
Honoured to have been invited to speak this morning at Hospital for Special Surgery (HSS), Manhattan, New York on CMCJ arthroplasty for thumb base osteoarthritis.
With recent FDA approval, CMCJ arthroplasty is now entering early clinical adoption in the United States, in contrast to its more established use in parts of Europe. We discussed an evidence-based overview of the condition and its management, covering disease biology, patient selection, indications and contraindications, surgical technique, complications, and reported outcomes.
Thank you to Drs Scott Wolfe Duretti Fufa Samir Trehan and Steve Lee for the invitation and for an open, high-quality discussion on how this evolving option may integrate into current approaches to thumb CMCJ osteoarthritis.
